These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3372029)

  • 1. Single and multiple dose pharmacokinetics of ciprofloxacin in gynecological tissues.
    Gerstner GJ; Dalhoff A; Weuta H
    Infection; 1988; 16 Suppl 1():S24-8. PubMed ID: 3372029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
    Portmann R; Hansz C; Stiglmayer R; Weidekamm E
    J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
    [No Abstract]   [Full Text] [Related]  

  • 3. Penetration of pefloxacin into gynaecological tissues.
    Bouvet O; Bressolle F; Courtieu C; Galtier M
    J Antimicrob Chemother; 1992 May; 29(5):579-87. PubMed ID: 1624396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
    Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
    Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of oral fluconazole into gynecological tissues.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Ito T; Ito K; Tamaya T
    Antimicrob Agents Chemother; 1999 Jan; 43(1):148-51. PubMed ID: 9869580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.
    Whelton A; Blanco LJ; Carter GG; Craig TJ; Bryant HH; Herbst DV; King TM
    Obstet Gynecol; 1980 Jan; 55(1):28-32. PubMed ID: 7352059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance of (14,15-3H)d,1-norgestrel from plasma and its distribution in the reproductive tract of women.
    Uniyal JP; Buckshee K; Sharma U; Laumas KR
    Acta Endocrinol (Copenh); 1976 Aug; 82(4):851-64. PubMed ID: 947291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of cefonicid into serum, salpinges, cervix and vaginal tissue.
    Goisis M; Grossi F; Soncini R; Gusmitta A
    J Chemother; 1991 Feb; 3(1):28-9. PubMed ID: 2019859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue penetration of Meropenem in patients undergoing gynecologic surgery.
    Gall S; Hemsell DL; McGregor JA; Martens MG; Pitkin D; Allen S
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S178-80. PubMed ID: 9126690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate.
    Lehtonen L; Wikberg R; Karhunen M; Kokkonen P; Tuominen R
    Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of ciprofloxacin into female pelvic tissues.
    Segev S; Rubinstein E; Shick J; Rabinovitch O; Dolitsky M
    Eur J Clin Microbiol; 1986 Apr; 5(2):207-9. PubMed ID: 2941283
    [No Abstract]   [Full Text] [Related]  

  • 14. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extravascular penetration of ciprofloxacin. A review.
    Bergan T
    Diagn Microbiol Infect Dis; 1990; 13(2):103-14. PubMed ID: 2196148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.
    Birmingham MC; Guarino R; Heller A; Wilton JH; Shah A; Hejmanowski L; Nix DE; Schentag JJ
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():43-8. PubMed ID: 10225571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.
    Goormans E; Dalhoff A; Kazzaz B; Branolte J
    Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic data in gynecological surgery using preoperative augmentin.
    Von Kobyletzki V
    Chemioterapia; 1987 Jun; 6(2 Suppl):262-4. PubMed ID: 3509406
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
    van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
    J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.